CORT
Price
$75.75
Change
-$2.64 (-3.37%)
Updated
Nov 13 closing price
Capitalization
7.96B
96 days until earnings call
Intraday BUY SELL Signals
VTVT
Price
$31.27
Change
+$0.27 (+0.87%)
Updated
Nov 13 closing price
Capitalization
119.24M
Intraday BUY SELL Signals
Interact to see
Advertisement

CORT vs VTVT

Header iconCORT vs VTVT Comparison
Open Charts CORT vs VTVTBanner chart's image
Corcept Therapeutics
Price$75.75
Change-$2.64 (-3.37%)
Volume$460.71K
Capitalization7.96B
vTv Therapeutics
Price$31.27
Change+$0.27 (+0.87%)
Volume$13.01K
Capitalization119.24M
CORT vs VTVT Comparison Chart in %
View a ticker or compare two or three
VS
CORT vs. VTVT commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CORT is a StrongBuy and VTVT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CORT: $75.75 vs. VTVT: $31.27)
Brand notoriety: CORT and VTVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CORT: 51% vs. VTVT: 219%
Market capitalization -- CORT: $7.96B vs. VTVT: $119.24M
CORT [@Biotechnology] is valued at $7.96B. VTVT’s [@Biotechnology] market capitalization is $119.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CORT’s FA Score shows that 1 FA rating(s) are green whileVTVT’s FA Score has 0 green FA rating(s).

  • CORT’s FA Score: 1 green, 4 red.
  • VTVT’s FA Score: 0 green, 5 red.
According to our system of comparison, CORT is a better buy in the long-term than VTVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CORT’s TA Score shows that 4 TA indicator(s) are bullish while VTVT’s TA Score has 3 bullish TA indicator(s).

  • CORT’s TA Score: 4 bullish, 6 bearish.
  • VTVT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CORT is a better buy in the short-term than VTVT.

Price Growth

CORT (@Biotechnology) experienced а +3.68% price change this week, while VTVT (@Biotechnology) price change was +22.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

CORT is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($7.96B) has a higher market cap than VTVT($119M). VTVT YTD gains are higher at: 124.496 vs. CORT (50.327). CORT has higher annual earnings (EBITDA): 104M vs. VTVT (-23.99M). CORT has more cash in the bank: 342M vs. VTVT (25.9M). VTVT has less debt than CORT: VTVT (79K) vs CORT (6.61M). CORT has higher revenues than VTVT: CORT (716M) vs VTVT (17K).
CORTVTVTCORT / VTVT
Capitalization7.96B119M6,692%
EBITDA104M-23.99M-433%
Gain YTD50.327124.49640%
P/E Ratio87.02N/A-
Revenue716M17K4,211,765%
Total Cash342M25.9M1,320%
Total Debt6.61M79K8,361%
FUNDAMENTALS RATINGS
CORT vs VTVT: Fundamental Ratings
CORT
VTVT
OUTLOOK RATING
1..100
1129
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
42100
SMR RATING
1..100
4299
PRICE GROWTH RATING
1..100
4636
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CORT's Valuation (88) in the Pharmaceuticals Other industry is in the same range as VTVT (96) in the Biotechnology industry. This means that CORT’s stock grew similarly to VTVT’s over the last 12 months.

CORT's Profit vs Risk Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for VTVT (100) in the Biotechnology industry. This means that CORT’s stock grew somewhat faster than VTVT’s over the last 12 months.

CORT's SMR Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for VTVT (99) in the Biotechnology industry. This means that CORT’s stock grew somewhat faster than VTVT’s over the last 12 months.

VTVT's Price Growth Rating (36) in the Biotechnology industry is in the same range as CORT (46) in the Pharmaceuticals Other industry. This means that VTVT’s stock grew similarly to CORT’s over the last 12 months.

CORT's P/E Growth Rating (8) in the Pharmaceuticals Other industry is significantly better than the same rating for VTVT (100) in the Biotechnology industry. This means that CORT’s stock grew significantly faster than VTVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORTVTVT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 29 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CORT
Daily Signal:
Gain/Loss:
VTVT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNNEF1.460.01
+0.68%
Canacol Energy Ltd.
NCBDF29.67N/A
N/A
Bandai Namco Holdings, Inc.
RNDXF0.02N/A
N/A
Randgold & Exploration Company Limited
KWPCF25.50N/A
N/A
Kewpie Corp
HKHC29.00-0.82
-2.75%
Horizon Kinetics Holding Corporation

CORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with VTVT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
-3.37%
VTVT - CORT
49%
Loosely correlated
+0.87%
TENX - CORT
41%
Loosely correlated
-4.29%
AGIO - CORT
41%
Loosely correlated
-2.50%
DNLI - CORT
40%
Loosely correlated
-2.11%
ARCT - CORT
37%
Loosely correlated
-4.43%
More

VTVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTVT has been loosely correlated with VANI. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VTVT jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTVT
1D Price
Change %
VTVT100%
+6.53%
VANI - VTVT
59%
Loosely correlated
+6.99%
CORT - VTVT
49%
Loosely correlated
-0.78%
GLMD - VTVT
40%
Loosely correlated
-4.17%
NKTX - VTVT
35%
Loosely correlated
-2.49%
CMND - VTVT
34%
Loosely correlated
-32.32%
More